Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726444 | SCV000344685 | uncertain significance | not provided | 2017-02-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000304844 | SCV000719635 | likely benign | not specified | 2017-05-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000804560 | SCV000944476 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000726444 | SCV001879877 | uncertain significance | not provided | 2021-01-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000726444 | SCV003831351 | uncertain significance | not provided | 2021-05-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279899 | SCV001467036 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-04-03 | no assertion criteria provided | clinical testing |